Funding Clinical Trials

Our Agency funds clinical trials testing promising stem cell or gene therapies for currently incurable diseases or disorders to help patients with unmet medical needs. For basic information about stem cell trials, visit our Clinical Trials 101 page. For a list of clinical trials that are a result of early-stage CIRM grants click here.

103

CIRM-FUNDED CLINICAL TRIALS

Disease AreasInvestigatorOrganizationPhaseTrial StatusTarget EnrollmentDetail
B cell cancers
Leukemia
Thomas J Kipps University of California, San Diego Phase 1/2 Active, not recruiting 102
B cell cancers
Leukemia
Dr. David B. Miklos Stanford University Phase 1 Active, not recruiting 56
B cell cancers
Leukemia
Leukemia, Acute Myeloid (AML)
Dr. Matthew H Porteus Stanford University Phase 1 Recruiting 22
B cell cancers Dr. Paul Finnegan Angiocrine Bioscience, Inc. Phase 3 Closed 130
Blood Cancer Dr. Edward Kavalerchik Angiocrine Bioscience, Inc. Phase 1 Completed 10
Blood Cancer Thomas J Kipps University of California, San Diego Phase 1 Completed 26
Blood Cancer
Solid Tumors
Dr. Irving L Weissman MD Stanford University Phase 1 Completed 88
Blood Cancer
Bone Marrow Transplant and Viral Infection
Michael A. Pulsipher Children’s Hospital of Los Angeles Phase 1/2 Active, not recruiting 60
Blood Cancer Dr. Edward Kavalerchik Angiocrine Bioscience, Inc. Phase 1/2 Completed 42
HIV-related Lymphoma
HIV/AIDS
Dr Mehrdad Abedi University of California, Davis Phase 1/2 Active, not recruiting 11
Leukemia, Acute Myeloid (AML) Dr. Colleen Delaney Nohla Therapeutics Inc Phase 2 Closed 146
Leukemia, Acute Myeloid (AML) Mark Chao Forty Seven Inc. Phase 1 Closed 258
Leukemia, Acute Myeloid (AML) Joseph Paul Woodard Immune-Onc Therapeutics Phase 1 Recruiting 106
Leukemia, Acute Myeloid (AML) Elizabeth Budde City of Hope, Beckman Research Institute Phase 1 Launching N/A
Multiple Myeloma Rajesh Belani MD Poseida Therapeutics, Inc. Phase 1 Closed 105